 |
 |

Staining Ability and Biocompatibility of Brilliant Blue G
Preclinical Study of Brilliant Blue G as an Adjunct for Capsular Staining
Toshio Hisatomi, MD, PhD;
Hiroshi Enaida, MD, PhD;
Hiroyoshi Matsumoto, MD;
Tadahisa Kagimoto, MD;
Akifumi Ueno, MD;
Yasuaki Hata, MD, PhD;
Toshiaki Kubota, MD, PhD;
Yoshinobu Goto, MD, PhD;
Tatsuro Ishibashi, MD, PhD
Arch Ophthalmol. 2006;124:514-519.
Objective To evaluate the effectiveness and biocompatibility of brilliant blue G (BBG) for capsular visualization for continuous curvilinear capsulorrhexis.
Methods The capsular staining ability of BBG was evaluated at graded concentrations of 10.0, 1.0, 0.5, 0.25, 0.1, and 0.01 mg/mL in enucleated pig's eyes. The biocompatibility of BBG was assessed in rat's eyes for 2 months. The eyes were analyzed using light, fluorescence, transmission electron, and scanning electron microscopy. TUNEL (terminal deoxynucleotidyl transferasemediated biotindeoxyuridine triphosphate nick-end labeling) was used to detect apoptotic cells, and endothelial cell counts were analyzed using scanning electron microscopy. The results were compared using indocyanine green and trypan blue.
Results The BBG improved capsular visualization, and a complete capsulorrhexis could be performed. In the rat model, no apparent toxic effect was observed using biomicroscopy during 2 months. Histologically, BBG showed satisfactory biocompatibility. Apoptotic cell death of the endothelial cells was detected in only the trypan blue group. In contrast to BBG, indocyanine green and trypan blue showed degeneration of corneal endothelial cells using transmission and scanning electron microscopy.
Conclusion The BBG contributed to better capsular visualization and caused no apparent complications to the corneal endothelium.
Clinical Relevance The BBG is effective and safe capsular staining for continuous curvilinear capsulorrhexis.
Author Affiliations: Departments of Ophthalmology (Drs Hisatomi, Enaida, Matsumoto, Kagimoto, Ueno, Hata, and Ishibashi) and Neurophysiology (Dr Goto), Graduate School of Medical Sciences, Kyushu University, and Department of Ophthalmology, University of Occupational and Environmental Health (Dr Kubota), Fukuoka, Japan.
CiteULike Connotea Del.icio.us Digg Reddit Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration
Diaz-Hernandez et al.
FASEB J. 2009;23:1893-1906.
ABSTRACT
| FULL TEXT
Intracellular Events in Retinal Glial Cells Exposed to ICG and BBG
Kawahara et al.
IOVS 2007;48:4426-4432.
ABSTRACT
| FULL TEXT
From the Library
Br. J. Ophthalmol. 2006;90:930-930.
FULL TEXT
|